Figure 5
From: Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1
Relationship between prognosis of cholangiocarcinoma (CCA) patients and aberrant MUC1 glycosylation. (a) 2D plot of the survival period after surgical dissection and M. amurensis hemagglutinin (MAH) signal indicating the most significant correlation with the survival month. (b) Relationship of MAH signal and tumor stage. (c) Kaplan–Meier analysis of MAH signal intensity. Analysis was performed with a MAH signal cutoff value of 0.5. (d) MAH-MY.1E12 double fluorescent immunostaining of CCA FFPE tissue sections from patients 12 and 19 shown in panel (a) and Supplementary Table S1. The clinical stages and survival periods were stage III and 26 months in patient 12 and stage IVa and 6 months in patient 19, respectively.
